What consumers might not realize, though, is that supplement manufacturers routinely, and legally, sell their products without first having to demonstrate that they are safe and effective.
The pet supplement market in North America was valued at approximately US$ 1,406.8 million in 2023 and is projected reach valuation of US$ 2,258.3 million by 2032 at a CAGR of 5.4% from 2023 to 2032.
(Headquarters: Chuo-ku, Tokyo; CEO: Megumi Tanaka) has launched sales of its original supplement brand “MIRAI LAB,” which contains β-Nicotinamide Mononucleotide (β-NMN), is now available in ...
We will continue to share our expertise and stay in conversation with colleagues to support the legitimacy and integrity of this important product category.” The company's new certification assures ...